PG
Prostatis Group’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $969K | Sell |
2,391
-33
| -1% | -$13.4K | 0.28% | 74 |
|
|
2025
Q1 | $1.21M | Sell |
2,424
-71
| -3% | -$35.3K | 0.38% | 56 |
|
|
2024
Q4 | $1.3M | Buy |
2,495
+28
| +1% | +$14.6K | 0.38% | 61 |
|
|
2024
Q3 | $1.53M | Sell |
2,467
-82
| -3% | -$50.7K | 0.5% | 51 |
|
|
2024
Q2 | $1.41M | Sell |
2,549
-82
| -3% | -$45.3K | 0.49% | 54 |
|
|
2024
Q1 | $1.53M | Sell |
2,631
-91
| -3% | -$52.9K | 0.58% | 49 |
|
|
2023
Q4 | $1.44M | Sell |
2,722
-107
| -4% | -$56.8K | 0.6% | 43 |
|
|
2023
Q3 | $1.43M | Sell |
2,829
-1,449,265
| -100% | -$734M | 0.7% | 33 |
|
|
2023
Q2 | $1.47M | Buy |
1,452,094
+1,449,270
| +51,320% | +$1.47M | 0.69% | 36 |
|
|
2023
Q1 | $1.63M | Sell |
2,824
-2
| -0.1% | -$1.15K | 0.86% | 28 |
|
|
2022
Q4 | $1.56M | Sell |
2,826
-1,278
| -31% | -$704K | 0.95% | 30 |
|
|
2022
Q3 | $2.08M | Buy |
4,104
+1,193
| +41% | +$605K | 2.4% | 13 |
|
|
2022
Q2 | $1.58M | Sell |
2,911
-1,431
| -33% | -$777K | 2.47% | 5 |
|
|
2022
Q1 | $2.56M | Buy |
4,342
+149
| +4% | +$88K | 2.06% | 20 |
|
|
2021
Q4 | $2.8M | Buy |
4,193
+1,000
| +31% | +$667K | 1.72% | 21 |
|
|
2021
Q3 | $1.82M | Hold |
3,193
| – | – | 1.09% | 29 |
|
|
2021
Q2 | $1.61M | Buy |
3,193
+4
| +0.1% | +$2.02K | 1.1% | 28 |
|
|
2021
Q1 | $1.46M | Buy |
3,189
+17
| +0.5% | +$7.76K | 1.14% | 24 |
|
|
2020
Q4 | $1.48M | Sell |
3,172
-649
| -17% | -$302K | 1.24% | 20 |
|
|
2020
Q3 | $1.69M | Sell |
3,821
-6
| -0.2% | -$2.65K | 1.6% | 19 |
|
|
2020
Q2 | $1.39M | Sell |
3,827
-2,347
| -38% | -$850K | 2.79% | 9 |
|
|
2020
Q1 | $1.75M | Sell |
6,174
-548
| -8% | -$155K | 2.49% | 16 |
|
|
2019
Q4 | $2.18M | Buy |
+6,722
| New | +$2.18M | 1.97% | 16 |
|